The Biotechnology drug development industry’s challenges are vast, not least being the translation of potential drugs into early clinical trials, and the development and implementation of the ensuing clinical trial strategy to MA.

The Swiss Biotech Association invites all industry partners to join us in Lausanne this September for this exciting event to address major challenges, including the growing complexity of trials, changing regulations, spiralling costs, patient access, but also to look a new opportunities and solutions with real world data science, adaptive clinical trial design, biomarkers and more.

 

Stay tuned for more information: https://www.swissbiotech.org

Event venue: Agora Cancer Research Centre, Lausanne Switzerland